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Carbapenem-Hydrolyzing
Metallo-ß-Lactamase from a
Nosocomial Isolate of
Pseudomonas aeruginosa
in France
To the Editor: The carbapenems (meropenem
and imipenem), the ß-lactams with the broadest
spectrum, are stable to most ß-lactamases (1).
Therefore, they are often used as antibiotics of
last resort for treating nosocomial infections due
to gram-negative bacteria resistant to other
ß-lactams. Resistance to carbapenems and
susceptibility to other ß-lactams in Pseudomonas
aeruginosa is common as a result of reduced drug
accumulation or increased expression of pump
efflux (1).
Several extended-spectrum ß-lactamases
have been reported in P. aeruginosa, but only
two, IMP-1 and VIM-1, possess an extended
hydrolysis profile that includes carbapenems
(2-5). The chromosome-borne and plasmid-
mediated carbapenem-hydrolyzing ß-lactamase,
IMP-1, has been described in several gram-
negative rods, including P. aeruginosa, P. cepacia,
Alcaligenes xylosoxydans, and Enterobacteri-
aceae isolates in Japan (4,6). Recently, a
chromosome-borne carbapenem-hydrolyzing
ß-lactamase, VIM-1, was reported from a clinical
isolate of P .  aeruginosa in Italy (5), and
uncharacterized carbapenem-hydrolyzing
ß-lactamases have been reported in the United
Kingdom and Portugal (7,8). The weakly related
IMP-1 and VIM-1 (31.4% amino acid identity) are
both zinc-dependent (metallo-enzymes) and
confer resistance to all ß-lactams except
monobactams (3,5).
In 1996, a 39-year-old French woman was
hospitalized in Marseille for chronic myelog-
enous leukemia, pancytopenia, and allogeneic
bone marrow transplantation. After a 15-day
stay in the transplantation unit, fever developed
and imipenem and amikacin were administered.
Despite this treatment, the patient died of septic
shock syndrome 5 days later. Three-day-old
blood cultures grew a carbapenem-resis-
tant  P. aeruginosa isolate. This P. aeruginosa
COL-1 isolate was resistant to most ß-lactams,
including piperacillin/tazobactam, imipenem,
meropenem, ceftazidime, cefepime (minimum
inhibitory concentrations [MICs] of 128, 32, 16,
64, 32 mg/L, respectively), amikacin, tobramycin,
gentamicin, netilmicin, and ciprofloxacin; how-
ever, the isolate was susceptible to aztreonam
(MIC determination, genetic techniques and
ß-lactamase assays are described elsewhere [9]).
A sonicate of crude extract of P. aeruginosa
COL-1 culture showed strong imipenem and
meropenem hydrolysis activity (0.7 mU/mg and
1.9 mU/mg; reference P. aeruginosa strain <0.05
mU/mg) by UV spectrophotometry with 0.1 mM
of substrate, after incubation in 50 mM
phosphate buffer at 30°C. This activity was lost
when the enzyme extract was preincubated with
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by addition of 1 mM ZnCl2, indicating the
presence of a metallo-carbapenem hydrolyzing
ß-lactamase. Isoelectric focusing revealed two
ß-lactamase bands of pI 5.6 and 9. Only the pI 5.6
ß-lactamase band was inhibited if the gel was
overlaid with edetic acid before nitrocefin was
added as the indicator substrate; the other pI
9 ß-lactamase likely corresponded to a naturally
occurring AmpC cephalosporinase. This pI 5.6
value differed from the pI values of the
carbapenem-hydrolyzing ß-lactamase previously
reported in P. aeruginosa (3-5,7,8). Polymerase
chain reaction amplification experiments were
negative when internal primers were used for
the only sequenced carbapenem-hydrolyzing
ß-lactamase genes from P. aeruginosa encoding
IMP-1 and VIM-1 and genomic DNA of
P. aeruginosa COL-1. Transfer of the carbapenem
resistance marker by conjugation to laboratory
strains of P. aeruginosa or Escherichia coli was
unsuccessful (9), but transformation by
electroporation of a putative plasmid extract
from  P. aeruginosa COL-1 in E. coli, followed by
selection onto amoxicillin-containing agar plates
(9), gave a ca. 45-kb plasmid that produced the
carbapenem-hydrolyzing ß-lactamase with a pI
value of 5.6. Thus, the carbapenem-hydrolyzing
ß-lactamase gene was plasmid-borne.
This case indicates the presence of a novel
carbapenem-hydrolyzing ß-lactamase in
P. aeruginosa in Europe, the first in France; its
spread in gram-negative rods, as reported for
IMP-1 in Japan, is of concern because, as seen
in this case, routine laboratory detection is
difficult and therapeutic options are extremely
limited.
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Population-Based Study of Invasive
Kingella kingae Infections
To the Editor: For most of the 3 decades since the
first description of Kingella kingae, this gram-
negative bacillus was considered a rare cause of
human disease (1). Since the late 1980s,
however, reports of infections by the organism in
young children have increased in the United
States, Western Europe, and Israel (2-6). The
rapid emergence of K. kingae as an important
cause of pediatric disease does not necessarily
imply that the organism is truly a new pathogen.
Better isolation techniques and awareness of the
bacterium by microbiology laboratories may
contribute to the apparent increase (4). Recent
studies have demonstrated that primary
isolation of K. kingae can be substantially
improved by injection of synovial fluid and bone
exudates into aerobic blood-culture bottles (4).
Synovial fluid may inhibit the growth of
K. kingae, and injection of the clinical specimen